Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
Related Questions
What is your approach to dosing rituximab in patients with multiple sclerosis?
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
How do you decide on initial and sequential anti-CD20 therapy for patients with multiple sclerosis given the availability of rituximab, ocrelizumab, ublituximab, and ofatumumab?
Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
Do you treat tumefactive multiple sclerosis differently than other forms of MS both in the acute and maintenance phase?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
How do you approach the "wearing off" phenomenon for patients with multiple sclerosis on B-cell-depleting therapies?
How would you treat chorea in a patient with Sjögren’s syndrome and positive beta 2 glycoprotein I antibodies?
